Comparison of a healthy miRNome with melanoma patient miRNomes: are microRNAs suitable serum biomarkers for cancer?
about
Transferring intercellular signals and traits between cancer cells: extracellular vesicles as "homing pigeons"New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid BiopsiesThe Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression AnalysisA restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomasAntiproliferative and Pro-Apoptotic Effects of MiR-4286 Inhibition in Melanoma Cells.High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.Examining plasma microRNA markers for colorectal cancer at different stages.Liquid biopsy utility for the surveillance of cutaneous malignant melanoma patientsSpecific miRNA Disease Biomarkers in Blood, Serum and Plasma: Challenges and Prospects.Total Extracellular Small RNA Profiles from Plasma, Saliva, and Urine of Healthy Subjects.Metastatic pathways in patients with cutaneous melanoma.MicroRNAs in melanoma development and resistance to target therapy.Non-coding RNAs including miRNAs, piRNAs, and tRNAs in human cancer.Circulating microRNAs as Candidate Biomarkers for the Surveillance of Melanoma Patients.miRCarta: a central repository for collecting miRNA candidates.Development and validation of a plasma-based melanoma biomarker suitable for clinical use.Small non-coding RNA profiling in human biofluids and surrogate tissues from healthy individuals: description of the diverse and most represented species.Circulating MicroRNA Biomarkers in Melanoma: Tools and Challenges in Personalised Medicine.miR-210 promotes human osteosarcoma cell migration and invasion by targeting FGFRL1.Alterations in patient plasma microRNA expression profiles following resection of metastatic melanomaSerum level of co-expressed hub miRNAs as diagnostic and prognostic biomarkers for pancreatic ductal adenocarcinomaLiquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review)
P2860
Q26747281-52DCD9E6-3CDB-4536-AFCC-436582408E09Q26748881-88F99254-2F82-479E-9247-C17886D4442AQ35947544-CD8228C3-3634-4665-8BA7-9A87A4B4B02EQ36091092-B3E4B4A4-1356-4B82-98EC-9FA78EDBA4E7Q36231416-37CA9EE5-B68F-4E39-9F90-9D8D0E8B9D2BQ36782525-B1AFB02D-FAD0-42CD-A7E2-12AF142A0E24Q36998271-CF82ADF9-9F5D-40D1-B7D3-3B81A27D58BBQ38700529-710933DF-15A8-43A1-9115-7189A5D54F0EQ38886081-E360C6AB-D5F0-40E0-81DE-ADCC06B380D7Q38901829-43758D76-4746-4BA9-B952-7A3C7CE67657Q39024316-CFFC0A8E-636C-4B21-85C8-DAF9C059C89EQ39101272-2FFECEAC-FD77-4A4F-9924-4E3B9E3F2C36Q41533763-8B2BB990-476B-4A25-B77A-72853A66A807Q41763210-1E908021-73D9-4B29-BA82-8D9828A2F572Q47152432-E7E20FE0-C66D-4F69-BFD5-497DAFEACAB6Q47557515-DD5333C5-D019-4FF9-9513-136AD9208F3CQ50105758-25BAD8AF-3B3E-4B68-83FA-A1BD97F2E9D7Q55428812-80467469-CB2F-4F4F-8A2D-9F466C063B4BQ55691098-6CEE7342-6343-41D3-A573-E63C9536D29DQ56334030-70CFBC67-4B16-4160-8872-C17690C507E4Q58573918-79E59FAE-7F1D-43FF-819C-BA635273C5E0Q58799160-A808A7C0-1EC0-4B14-A43E-51FE096771E2
P2860
Comparison of a healthy miRNome with melanoma patient miRNomes: are microRNAs suitable serum biomarkers for cancer?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Comparison of a healthy miRNom ...... e serum biomarkers for cancer?
@ast
Comparison of a healthy miRNom ...... e serum biomarkers for cancer?
@en
type
label
Comparison of a healthy miRNom ...... e serum biomarkers for cancer?
@ast
Comparison of a healthy miRNom ...... e serum biomarkers for cancer?
@en
prefLabel
Comparison of a healthy miRNom ...... e serum biomarkers for cancer?
@ast
Comparison of a healthy miRNom ...... e serum biomarkers for cancer?
@en
P2093
P2860
P921
P356
P1433
P1476
Comparison of a healthy miRNom ...... e serum biomarkers for cancer?
@en
P2093
Casandra Walters
Christiane Margue
Demetra Philippidou
Dorothée Nashan
Iris Behrmann
Jochen G Schneider
Nicolas Beaume
Stephanie Kreis
Susanne Reinsbach
P2860
P304
12110-12127
P356
10.18632/ONCOTARGET.3661
P407
P577
2015-05-01T00:00:00Z